Senior Leadership at the UT Southwestern Simmons Cancer Center is comprised of the Director, Deputy Director, three Associate Directors representing basic, clinical and population research and the Associate Director for Administration. These leaders are responsible for collaborations across the scientific programs of the Center, direction and strategic planning, oversight of shared resources, education, and development of community outreach and budgetary oversight. Over the past four years. Dr. James Willson has provided vision and strong leadership as Director of UT Southwestern Simmons Cancer Center. Dr. Joan Schiller was appointed Deputy Director in 2006 and has led the development of the Center's disease oriented teams and an enabling clinical research infrastructure that has been integrated with the Medical Center's affiliated hospitals. Dr. Michael White serves as Associate Director for Basic Research and in this role has been instrumental in the development of the Center's basic research programs and the engagement of UT Southwestern cancer researchers into the Cancer Center. Dr. David Euhus serves as Associate Director for Clinical Research and in this role he is responsible for developing and maintaining a robust clinical trials enterprise for the Cancer Center and in partnership with the Deputy Director has responsibility for the oversight of the clinical trials support resources and the protocol review and monitoring system. Dr. Celette Sugg Skinner, who joined the Simmons Cancer Center in 2007, serves as Associate Director for Population Science. In this role she is leading the development of a research program in population science and cancer control and building interactions between basic and clinical faculty across the cancer control spectrum. This leadership team functions as a cohesive group that together has catalyzed new transdisciplinary collaborations and coordination that are transforming the cancer research environment at UT Southwestern.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
United States
Zip Code
Stallings, Nancy R; O'Neal, Melissa A; Hu, Jie et al. (2018) Pin1 mediates A?42-induced dendritic spine loss. Sci Signal 11:
Sudhan, Dhivya R; Schwarz, Luis J; Guerrero-Zotano, Angel et al. (2018) Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial. Clin Cancer Res :
Pruitt, Sandi L; Werner, Claudia L; Borton, Eric K et al. (2018) Cervical Cancer Burden and Opportunities for Prevention in a Safety-Net Healthcare System. Cancer Epidemiol Biomarkers Prev 27:1398-1406
Shay, Laura A; Baldwin, Austin S; Betts, Andrea C et al. (2018) Parent-Provider Communication of HPV Vaccine Hesitancy. Pediatrics 141:
Murphy, Caitlin C; Sigel, Bianca M; Yang, Edward et al. (2018) Adherence to colorectal cancer screening measured as the proportion of time covered. Gastrointest Endosc 88:323-331.e2
Taylor 4th, Clinton A; An, Sung-Wan; Kankanamalage, Sachith Gallolu et al. (2018) OSR1 regulates a subset of inward rectifier potassium channels via a binding motif variant. Proc Natl Acad Sci U S A 115:3840-3845
Deng, Mi; Gui, Xun; Kim, Jaehyup et al. (2018) LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature 562:605-609
Lee, Simon Craddock; Higashi, Robin T; Sanders, Joanne M et al. (2018) Effects of program scale-up on time to resolution for patients with abnormal screening mammography results. Cancer Causes Control 29:995-1005
Singal, Amit G; Tiro, Jasmin A; Murphy, Caitlin C et al. (2018) Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial. Hepatology :
Ludlow, Andrew T; Wong, Mandy Sze; Robin, Jerome D et al. (2018) NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer. Nat Commun 9:3112

Showing the most recent 10 out of 501 publications